O'neil Global Advisors, Inc. / CRSP
O'neil Global Advisors, Inc.’s Crispr Therapeutics AG Position
Does O'neil Global Advisors, Inc. own Crispr Therapeutics AG (CRSP)? Not currently — the last reported position was 168.7K shares worth $11M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$11M
Q3 2025
Shares
168.7K
% of Portfolio
+2.01%
Quarters Held
1
position exited
Position History CRSP
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 168.7K | $11M | +2.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See O'neil Global Advisors, Inc.’s full portfolio or all institutional holders of CRSP.